Sun, Dec 21, 2014, 7:54 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Sunesis Pharmaceuticals, Inc. Message Board

  • homebuilder_watcher homebuilder_watcher Mar 6, 2013 8:34 AM Flag

    Interesting note from Leerink this morning

    "Given numerous approaching Vosaroxin catalysts not reflected in our current model and $10 valuation, we begin a multiple part series exploring upside to our valuation possibly driven by these catalysts. We start with a 2Q13 LI-1 trial front line (FL) AML update that will suggest whether Vosaroxin could become a meaningful FL therapy....If either arm proceeds to Stage-2, this would significantly de-risk potential FL approval and lead us to increase our valuation to $16. For now, we reiterate our Outperform rating and $10 valuation on SNSS.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
2.53-0.05(-1.94%)Dec 19 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.